• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病性视网膜病变

Diabetic retinopathy.

作者信息

L'Esperance F A

出版信息

Med Clin North Am. 1978 Jul;62(4):767-85.

PMID:355741
Abstract

The only methods of treatment for severe diabetic retinopathy that have been proved effective by controlled clinical trials are photocoagulation and pituitary ablation. It must be noted that photocoagulation and pituitary ablation impede but do not cure diabetic retinopathy. Pars plana vitrectomy can be highly effective for removing blood from the vitreous of the eye, allowing better vision, particularly if the retina has been shown to be functional by electrophysiologic testing and ultrasonography. In addition, vitrectomy allows the ophthalmologist to visualize, evaluate, and treat the diabetic retina by photocoagulation or other methods. Attempts at better regulation of blood sugar have reduced the development of microangiopathy in experimental animals and recently in man. The benefits of rigorous regulation of the blood sugar has been noted in a policy statement by the American Diabetes Association. The development of a practical, beneficial pancreas has been undertaken, and may be required in order to reap the full benefits of rigorous blood sugar control. It has been recommended that all patients be evaluated by an ophthalmologist as soon as they have been found to have diabetes, that all diabetics be examined ophthalmologically on an annual basis, and that patients with significant retinopathy be seen at 6 month or shorter intervals by their ophthalmologist. The evaluation and treatment of diabetic retinopathy has progressed enormously during the past decade. It is hoped that the cause of diabetic microangiopathy and retinopathy will be discovered in the near future so that treatment will ultimately cure rather than control the process of diabetic retinopathy.

摘要

经对照临床试验证明有效的重度糖尿病视网膜病变的唯一治疗方法是光凝法和垂体切除术。必须指出的是,光凝法和垂体切除术会阻碍但无法治愈糖尿病视网膜病变。玻璃体切割术对于清除眼内玻璃体中的血液非常有效,能改善视力,特别是在视网膜经电生理测试和超声检查显示仍有功能时。此外,玻璃体切割术使眼科医生能够通过光凝法或其他方法观察、评估和治疗糖尿病视网膜。在实验动物以及最近在人类中,更好地控制血糖的尝试减少了微血管病变的发生。美国糖尿病协会的一份政策声明中提到了严格控制血糖的益处。目前正在研发一种实用且有益的胰腺,可能需要这样做才能充分获得严格控制血糖的全部益处。建议所有被诊断出患有糖尿病的患者尽快由眼科医生进行评估,所有糖尿病患者每年进行眼科检查,患有严重视网膜病变的患者应由眼科医生每6个月或更短时间进行一次检查。在过去十年中,糖尿病视网膜病变的评估和治疗取得了巨大进展。希望在不久的将来能发现糖尿病微血管病变和视网膜病变的病因,以便最终能治愈而非仅仅控制糖尿病视网膜病变的进程。

相似文献

1
Diabetic retinopathy.糖尿病性视网膜病变
Med Clin North Am. 1978 Jul;62(4):767-85.
2
Diabetic retinopathy: current concepts of evaluation and treatment.糖尿病视网膜病变:评估与治疗的当前概念
Clin Endocrinol Metab. 1986 Nov;15(4):933-69. doi: 10.1016/s0300-595x(86)80081-0.
3
Diabetic retinopathy: current concepts and emerging therapy.糖尿病视网膜病变:当前的概念和新兴疗法。
Endocrinol Metab Clin North Am. 2013 Dec;42(4):721-45. doi: 10.1016/j.ecl.2013.08.001.
4
Management of proliferative diabetic retinopathy.增殖性糖尿病视网膜病变的管理
Compr Ophthalmol Update. 2007 Sep-Oct;8(5):245-56.
5
The vitreous in diabetic retinopathy.糖尿病视网膜病变中的玻璃体
Trans Ophthalmol Soc U K (1962). 1975;95(3):407-11.
6
Ocular oxygenation and the treatment of diabetic retinopathy.眼部氧合作用与糖尿病视网膜病变的治疗
Surv Ophthalmol. 2006 Jul-Aug;51(4):364-80. doi: 10.1016/j.survophthal.2006.04.005.
7
The rationale of photocoagulation therapy for proliferative diabetic retinopathy: a review and a model.增殖性糖尿病视网膜病变光凝治疗的原理:综述与模型
Ophthalmic Surg. 1980 Apr;11(4):235-45.
8
Proliferative diabetic retinopathy and patient age: presentation, prognosis, and management.增殖性糖尿病视网膜病变与患者年龄:表现、预后及管理
Int Ophthalmol Clin. 1984 Winter;24(4):71-82.
9
Photocoagulation in diabetic retinopathy: II. Methodology.
Int Ophthalmol Clin. 1978 Winter;18(4):107-19.
10
Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation?视网膜光凝术不影响增殖性糖尿病视网膜病变患者眼内胰岛素样生长因子-I(IGF-I)、胰岛素样生长因子-II(IGF-II)和胰岛素样生长因子结合蛋白3(IGF-BP3)的水平——这是否为生长抑素类似物与视网膜光凝术联合治疗增殖性糖尿病视网膜病变提供了证据?
Horm Metab Res. 2001 May;33(5):312-6. doi: 10.1055/s-2001-15283.

引用本文的文献

1
Dissemination of the published results of an important clinical trial: an analysis of the citing literature.一项重要临床试验发表结果的传播:对引用文献的分析
Bull Med Libr Assoc. 1981 Jul;69(3):301-6.
2
[Hyperglycemia and the complications of maturity-onset diabetes].[高血糖与成年型糖尿病并发症]
Can Med Assoc J. 1980 Apr 19;122(8):884-9.
3
Vascular and neural changes in the rat optic nerve following induction of diabetes with streptozotocin.
J Anat. 1986 Feb;144:145-52.